N
MRNS

Nuveen’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Nuveen’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-139,752
Closed -$1.26M – 3464
2024
Q1 		$1.26M Hold
139,752
– – ﹤0.01% 2597
2023
Q4 		$1.52M Buy
139,752
+1,475
+1% +$11.1K ﹤0.01% 2535
2023
Q3 		$1.11M Sell
138,277
-1,200
-0.9% -$9.98K ﹤0.01% 2530
2023
Q2 		$1.51M Buy
+139,477
New +$1.19M ﹤0.01% 2483
2022
Q2 		– Sell
-111,914
Closed -$1.05M – 3541
2022
Q1 		$1.05M Buy
111,914
+1,363
+1% +$13.5K ﹤0.01% 2806
2021
Q4 		$1.31M Sell
110,551
-8,772
-7% -$101K ﹤0.01% 2752
2021
Q3 		$1.36M Sell
119,323
-9,133
-7% -$126K ﹤0.01% 2852
2021
Q2 		$736K Buy
128,456
+42,482
+49% +$683K ﹤0.01% 3104
2021
Q1 		$1.33M Buy
85,974
+2,073
+2% +$30K ﹤0.01% 2789
2020
Q4 		$1.02M Sell
83,901
-4,682
-5% -$65.3K ﹤0.01% 2797
2020
Q3 		$1.14M Buy
88,583
+12,459
+16% +$108K ﹤0.01% 2632
2020
Q2 		$773K Sell
76,124
-76,939
-50% -$708K ﹤0.01% 2728
2020
Q1 		$1.24M Buy
153,063
+55,116
+56% +$477K ﹤0.01% 2414
2019
Q4 		$847K Buy
97,947
+19,423
+25% +$109K ﹤0.01% 2743
2019
Q3 		$484K Buy
78,524
+31,825
+68% +$257K ﹤0.01% 2957
2019
Q2 		$776K Buy
+46,699
New +$811K ﹤0.01% 2844

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen's MRNS Position: Q2 2024 in Review

Nuveen sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 139,752 shares — an estimated $1.26M sold.

Nuveen first reported a position in MRNS in Q2 2019 and held it in 16 quarters. The position peaked at $1.52M in Q4 2023. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Nuveen reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Nuveen sold 139,752 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $1.26M.
  • Nuveen first reported a position in Marinus Pharmaceuticals, Inc in Q2 2019 and held it in 16 quarters.
  • Nuveen's Marinus Pharmaceuticals, Inc position peaked at $1.52M in Q4 2023.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.